WeVote

Bill

Bill

HB 3109

Relating to the Occupational Pneumoconiosis Board

2025 Regular Session Introduced by Jordan Bridges and 6 co-sponsors

Expands Illinois SBIR/STTR matching grants: Phase I up to $75,000 and new Phase II up to $250,000 (subject to appropriation) to boost in-state R&D and Phase II commercialization.

To House Health and Human Resources
0
WeVote Research Nonpartisan
Bill Summary · HB 3109

Summary — HB 3109 (DCEO — SBIR/STTR Grants)

Status: Introduced Feb 20, 2025; House actions through Apr 28, 2025. Rule 19(a) / Re‑referred to Rules Committee (4/11/2025). Companion: SB 1499.

Purpose

Amends Section 605‑1055 of the Department of Commerce and Economic Opportunity (DCEO) Law to expand and clarify Illinois matching grants for businesses that receive federal SBIR (Small Business Innovation Research) or STTR (Small Business Technology Transfer) awards. The bill raises the Phase I match cap and establishes a Phase II matching program (subject to appropriation) to encourage in‑state R&D, Phase II applications, and commercialization activity.

Key provisions / changes

  • Increases the maximum Phase I matching grant from $50,000 to $75,000.
  • Establishes a Phase II matching grant program (subject to appropriation) with a maximum match of $250,000 per award.
  • Specifies payment schedules for both Phase I and Phase II matching grants.
  • Maintains eligibility, reporting, and in‑state performance requirements; sets per‑year and lifetime award limits.

Eligibility (business must meet all)

  • For‑profit business with principal place of business in Illinois.
  • Received an SBIR/STTR Phase I award from a participating federal agency in response to a specific federal solicitation.
  • Submitted final Phase I report, demonstrated agency interest in a Phase II proposal, and submitted a Phase II proposal (to receive full Phase I match).
  • Meets all federal SBIR/STTR requirements.
  • No duplicative concurrent funding.
  • Certifies that at least 51% of the research described in the Phase II proposal will be conducted in Illinois and will remain Illinois‑based for the Phase II duration.
  • Demonstrates ability to conduct the Phase II research in its federal Phase II proposal.

Grant amounts and payment schedule

  • Phase I match: up to $75,000. Payment: 75% upon receipt of the federal Phase I award and application to DCEO; remaining 25% upon submission of Phase II application and acceptance of Phase I report by the federal agency.
    • Limits: one Phase I grant per business per year; one grant per federal proposal; lifetime max of 5 Phase I awards.
  • Phase II match (subject to appropriation): up to $250,000. Payment: 50% upon receipt of the federal Phase II award and application to DCEO; 50% upon submission of the Phase II final report to the federal agency.
    • Limits: one Phase II grant per business per year; one grant per federal proposal; lifetime max of 2 Phase II awards.

Application / administration

  • Businesses apply under oath on a DCEO form requiring business identity, organizational form, principals, acknowledgment of receipt of Phase I report and Phase II proposal by the federal agency, and other evaluative information.
  • Program administered by DCEO; Phase II grants are explicitly subject to appropriation.

Procedural / timeline notes

  • Introduced in House (Rep. Barbara Hernandez). House Amendment 001 filed Mar 10, 2025; adopted in committee (Mar 12). Committee reported favorably (Apr 9). Placed on General State Calendar and read twice (Mar–Apr 2025). Re‑referred to Rules under Rule 19(a) on Apr 11, 2025; later actions include being laid on table subject to call (Apr 28, 2025).

Potential impact

  • Directly increases state support for Illinois small businesses pursuing federal SBIR/STTR awards, strengthening incentives to apply for Phase II funding and to keep R&D work in Illinois.
  • Fiscal impact depends on appropriations for Phase II matching grants; Phase I increases raise potential state outlays relative to current law but remain subject to existing program administration and award limits.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.